No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Oral Simnotrelvir Shortens COVID-19 Symptom Duration in Adult Patients with Mild-to-Moderate COVID-19

byMinjee Kim

January 18, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Oral Simnotrelvir Shortens COVID-19 Symptom Duration in Adult Patients with Mild-to-Moderate COVID-19

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Machine-learning-based models found to have predictive abilities no better than chance in out-of-sample evaluations

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026

Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026

Soaring rates of peripheral artery disease, now over 200 million cases worldwide

Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease

#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with HER2-positive gastro-esophageal cancer

Risk factors associated with cognitive impairment development in older adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Oral Simnotrelvir Shortens COVID-19 Symptom Duration in Adult Patients with Mild-to-Moderate COVID-19

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Machine-learning-based models found to have predictive abilities no better than chance in out-of-sample evaluations

Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease

RelatedReports

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

2 Minute Medicine Rewind August 3rd, 2026

Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease

#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with HER2-positive gastro-esophageal cancer

Risk factors associated with cognitive impairment development in older adults

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits